Literature DB >> 19829718

Successful use of sacral neuromodulation after failed bladder augmentation.

Nathan T Rasmussen1, Michael L Guralnick, R Corey O'Connor.   

Abstract

Sacral neuromodulation has become a standard minimally invasive therapy for refractory urinary urge/frequency and urge incontinence. Prior to the widespread use of sacral neuromodulation, augmentation cystoplasty was a standard treatment for refractory overactive bladder (OAB). The use of sacral neuromodulation following bladder augmentation has not been previously reported in the literature. We report 2 cases of successful sacral neuromodulation in patients with OAB refractory to bladder augmentation.

Entities:  

Year:  2009        PMID: 19829718      PMCID: PMC2759661          DOI: 10.5489/cuaj.1161

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  5 in total

1.  Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation.

Authors:  W A Scheepens; G A Van Koeveringe; R A De Bie; E H J Weil; Ph E V Van Kerrebroeck
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

2.  Results of ileocystoplasty.

Authors:  W E GOODWIN; R D TURNER; C C WINTER
Journal:  J Urol       Date:  1958-12       Impact factor: 7.450

Review 3.  How sacral nerve stimulation neuromodulation works.

Authors:  Wendy W Leng; Michael B Chancellor
Journal:  Urol Clin North Am       Date:  2005-02       Impact factor: 2.241

4.  Interventions for detrusor overactivity: the case for multimodal therapy.

Authors:  Roger Dmochowski
Journal:  Rev Urol       Date:  2002

5.  Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience.

Authors:  David E Rapp; Alvaro Lucioni; Erin E Katz; R Corey O'Connor; Glenn S Gerber; Gregory T Bales
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

  5 in total
  4 in total

Review 1.  Sacral nerve modulation in overactive bladder.

Authors:  John A Occhino; Steven W Siegel
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

Review 2.  Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

Authors:  Evan Shreck; Kevin Gioia; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

3.  The surgical management of the refractory overactive bladder.

Authors:  Nikhil Vasdev; Benjamin D Biles; Raveen Sandher; Tahseen S Hasan
Journal:  Indian J Urol       Date:  2010-04

4.  Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery.

Authors:  Ngoc-Bich Le; Ja-Hong Kim
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.